CGEN — COMPUGEN LTD
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1119774 ·
Last close
$2.38
Market Cap
$225.44M
52W High
$3.24
52W Low
$1.37
ADV30
260,587
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 2,176,000 | 352,000 | -9,017,000 | -7,669,000 | 145,861,000 | 12,435,000 | 50,508,000 |
| Dec 2025 | 67,332,000 | 63,796,000 | 56,043,000 | 56,845,000 | 156,570,000 | 90,597,000 | 53,839,000 |
| Sep 2025 | 1,891,000 | 241,000 | -7,893,000 | -6,979,000 | 97,845,000 | 7,455,000 | 54,019,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-453,415,000
Inventory
—
Receivables
$2,338,000
ST Investments
$122,511,000
EBIT TTM
$30,704,000
Pretax Income TTM
$34,883,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$74,001,000
EBITDA
$30,676,000
Free Cash Flow
$22,217,000
Enterprise Value
$111,691,640
Total Cash
$125,300,000
Total Debt
$3,023,000
Shares Out
94,724,146
Trailing EPS
$0.38
Book Value
$0.94
ROE
50.6%
ROA
15.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 72,764,000 | 31,326,000 | 35,343,000 | 156,570,000 | 53,839,000 | 102,731,000 | 31,634,000 |
| Dec 2024 | 27,864,000 | -14,891,000 | -14,231,000 | 114,995,000 | 60,081,000 | 54,914,000 | 49,604,000 |
| Dec 2023 | 33,459,000 | -12,992,000 | -18,754,000 | 121,334,000 | 55,775,000 | 65,559,000 | -35,886,000 |
| Dec 2022 | 7,500,000 | -35,374,000 | -33,694,000 | 94,176,000 | 16,496,000 | 77,680,000 | -34,113,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.37
Max Pain — expiry 2026-12-18
max pain strike: $2.50 · spot: $2.33 · call oi: 738 · put oi: 648
Expected Move to 2026-12-18:
±$0.81
(34.55%) —
implied range
$1.52 –
$3.13
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AVXL | ANAVEX LIFE SCIENCES CORP. | $220.62M | $2.38 | — |
| PLX | Protalix BioTherapeutics, Inc. | $219.15M | $2.72 | — |
| ALEC | Alector, Inc. | $217.73M | $1.95 | — |
| CMPX | Compass Therapeutics, Inc. | $203.50M | $1.13 | — |
| PALI | PALISADE BIO, INC. | $252.69M | $1.45 | — |
News headlines (Yahoo Finance, 1h cache)
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-08 11:00 · Yahoo
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ...
2026-08-06 01:01 · Yahoo
Compugen Q2 Earnings Call Highlights
2026-08-03 14:04 · Yahoo
Compugen Reports Second Quarter 2026 Results
2026-08-03 11:00 · Yahoo
Compugen to Participate in BTIG Biotechnology Conference 2026
2026-07-21 11:00 · Yahoo
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
2026-07-20 11:00 · Yahoo
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
2026-06-11 11:00 · Yahoo
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
2026-06-08 11:00 · Yahoo
Compugen Q1 Earnings Call Highlights
2026-05-18 14:08 · Yahoo
Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026
2026-09-22 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.